So appreciate your posts- thoughts of reason and things to
So appreciate your posts- thoughts of reason and things to think about.
Usually have so much to say in response to them- in the way of excited agreements, questions, 'ummm but I see it this way' comments, 'dang I wish I could have articulated that idea as well as that' thoughts, and tonight there is a new one. I had a "Oh noooo- Respert24 thinks THAT'' too- how sad and I might be compelled to actually do more than a thumbs up' moment.
So here I am. (Fairly intimidated by this group- with no investing or medical background - so I am at peace with usually being an observer/listener.)
Boring background so my 'moment' makes a bit of sense: just retired after years in government service (international relations and public health nutrition); not much comparatively but most of my retirement account and all (OK- a bit more than that) of my fun money in CYDY. Many hours researching it- from the initial angle of my continuing struggle to get a friend into the clinical trials.
Was able to hear the last of the call today. I get it- folks are nervous. I am too (figuring out which is the less eeky job- McDonalds or Bed, Bath and Beyond) - but more focused on the benefits of the dang thing (maybe a few more years of life for my friend). It gives me hope.
What tears me up is the idea that bureaucrats are an incompetent, lazy group- at best- or a malicious, non-caring, politically motivated group- at worst. I loved your examples of business delays. Add to that massive numbers of federal, state and local level government 'rules' that must be followed at every move. If not- anything you do- good or bad- gets 'thrown out of court' and is useless. You have all the responsibility- and no authority. You strive to find the balance between the 'I have rights including not paying taxes for a government because I think they do nothing for me' and 'I want this service yesterday' with all you do.
You work countless hours - for nothing as far as personal gain. I have worked 1,000 hours plus over my career for only the gain of the project and the good for others- which was all I was wanting. I used to watch my kid playing out of the window when he was a pre-teen while I was working 80 hours a week- week after week. To clarify- many government employees, like me, do not get overtime pay- your job is your job.
The absolute frustration that the FDA staff (perhaps other than the 'newly appointed' ones) at every level must be feeling right now must be tremendous. (Your child hearing the constant innuendos about despicable government/FDA employees really hurts and is a constant parenting challenge when you care about their life-view.)
IMHO- the 'biggies' -in business and government- are making some errors (e.g. plasma- really?!!). Just makes me sad that the worker bee 'bureaucrats' pay the price.
Sorry hun- (old lady from the south with a few belts so I can't help it--) for this rant. Feels good to unload this to a person I respert . . . . . .. . . .
9
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...
Continue Reading
Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...
Continue Reading
When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...
Continue Reading
Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....
Continue Reading
Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...
Continue Reading
Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...
Continue Reading
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...
Continue Reading
Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...
Continue Reading
Top 5 Most Recently Viewed Articles
RBC Initiates Coverage of Oracle Corporation RBC Capital analysts have recently launched their coverage of Oracle Corporation (NYSE: ORCL) with a Sector Perform rating, setting a price target of $165. This decision comes amidst growing concerns regarding the competitive landscape and the sustainability of Oracle's recent growth initiatives. Concerns Over Competition While...
Continue Reading
Oakwood Homes Introduces the Coach House Collection Today, Oakwood Homes has proudly introduced the new Coach House collection, located in their latest master-planned community. This exciting development enhances the options available for homebuyers seeking affordable and designed living spaces that fit their lifestyle. Details of the Coach House Collection The Coach...
Continue Reading
Insights into Lab Data Management by IDBS IDBS, a leading global provider of cloud software for BioPharma companies, has recently released insightful findings from their survey on lab data management. This survey captured the views of 856 BioPharma professionals regarding the current challenges and priorities in the field. Key Findings from the Survey The IDBS platform...
Continue Reading
Investigation into the Sale of Adams Resources & Energy, Inc. Halper Sadeh LLC, a prominent law firm specializing in investor rights, has initiated an investigation into the recent sale of Adams Resources & Energy, Inc. (NYSE: AE). The sale involves an agreement with an affiliate of Tres Energy LLC, with an offer price of $38.00 per share in cash. The main focus of this...
Continue Reading
Introduction to CLIQ Digital AG's Transition CLIQ Digital AG has recently announced pivotal changes regarding the trading of its shares. The management team has decided to shift the company's shares to the Basic Board of the open market on the Frankfurt Stock Exchange, marking a significant milestone in its operational strategy. Details of the Transition Following the...
Continue Reading
End -->